Around this time last year we had the appointment of Gerry Zhao as VP of Corporate Development to “work with CEO Jon Pilcher on all partnering, M&A and investor activities”.
Gerry has deep connections in Asia, especially China.
Today we have the appointment of Joe Basile as a Non-Executive Director. Joe is said to have “deep experience in corporate mergers and acquisitions, capital management and overseeing expansion activities across multiple countries”.
Joe is currently CFO for the iNova Group, which is based in Singapore but covers predominantly Asia and ANZ. He previously worked as Finance Director for Novartis, again in Asia and ANZ.
Interesting that both M&A partnering and capital management appointees have deep networks in Asia, rather than the US or Europe. A sign of future direction?
Ann: Neuren appoints Joe Basile to board of directors, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |